Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Medtronic
Moodys
Dow
AstraZeneca

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Albaconazole


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Albaconazole?

Albaconazole is an investigational drug.

There have been 6 clinical trials for Albaconazole. The most recent clinical trial was a Phase 2 trial, which was initiated on July 16th 2008.

The most common disease conditions in clinical trials are Onychomycosis, Tinea Pedis, and Tinea. The leading clinical trial sponsors are GlaxoSmithKline, Stiefel, a GSK Company, and J. Uriach and Company.

Recent Clinical Trials for Albaconazole
TitleSponsorPhase
Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas DiseaseEisai Co., Ltd.Phase 2
Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas DiseaseDrugs for Neglected DiseasesPhase 2
A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a CapsuleGlaxoSmithKlinePhase 1

See all Albaconazole clinical trials

Clinical Trial Summary for Albaconazole

Top disease conditions for Albaconazole
Top clinical trial sponsors for Albaconazole

See all Albaconazole clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Medtronic
Moodys
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.